CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Axcess Global Sciences LLC v. VitaNav Inc.

1:25-cv-00170

Overview

Case Number 1:25-cv-00170
Filing Date 2025-02-12
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

VitaNav Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Axcess Global Sciences LLC Operating Company

Represented By

3 Attorneys Listed

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Andrew Mark Moshos

Potter Anderson & Corroon LLP

Tel: +1 (302) 984-6288

1313 North Market Street, 6th Floor

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US12128020
Administration of R-beta-hydroxybutyrate and related compounds in humans
Filed: 2024-02-29
Issued: 2024-10-29
Active (17.3 yrs remaining)
Expires: 2044-02-29
US12109182
Administration of R-beta-hydroxybutyrate and related compounds in humans
Filed: 2021-07-02
Issued: 2024-10-08
Active (12.4 yrs remaining)
Expires: 2039-04-29
US12090129
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
Filed: 2023-07-03
Issued: 2024-09-17
Active (16.6 yrs remaining)
Expires: 2043-07-03
US11020362
Beta-hydroxybutyrate mixed salt compositions and methods of use
Filed: 2019-12-19
Issued: 2021-06-01
Active (13.1 yrs remaining)
Expires: 2039-12-19
US11241403
Beta-hydroxybutyrate mixed salt compositions and methods of use
Filed: 2021-03-11
Issued: 2022-02-08
Active (14.3 yrs remaining)
Expires: 2041-03-11

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Docket Entries

(32 total)
Pleading / Complaint

COMPLAINT for Patent Infringement with Jury Demand against VitaNav Inc. ( Filing fee $ 405, receipt number ADEDC-4612884) - filed by Axcess Global Sciences LLC. (Attachments: # 1 Exhibits A-F, # 2 Civil Cover Sheet)(mrr) (Entered: 02/12/2025)

Entry #1 • 2025-02-12
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 02/12/2025)

Entry #2 • 2025-02-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 12,128,020 B2; US 12,109,182 B2; US 12,090,129 B2; US 11,020,362 B2 ; US 11,241,403 B2. (mrr) (Entered: 02/12/2025)

Entry #3 • 2025-02-12
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Axcess Global, LLC for Axcess Global Sciences LLC filed by Axcess Global Sciences LLC. (mrr) (Entered: 02/12/2025)

Entry #4 • 2025-02-12
1

Summons Issued as to VitaNav Inc. on 2/12/2025. (mrr) (Entered: 02/12/2025)

Entry #5 • 2025-02-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc